Leohr, Jennifer
Dellva, Mary Anne
Carter, Kallin
LaBell, Elizabeth
Linnebjerg, Helle
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data
https://doi.org/10.1007/s40262-021-01030-0
Documents that mention this clinical trial
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data
https://doi.org/10.1007/s40262-021-01030-0
Documents that mention this clinical trial
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data
https://doi.org/10.1007/s40262-021-01030-0
Documents that mention this clinical trial
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data
https://doi.org/10.1007/s40262-021-01030-0
Funding for this research was provided by:
Eli Lilly and Company
Article History
Accepted: 23 April 2021
First Online: 27 May 2021
Declarations
:
: This study was sponsored by Eli Lilly and Company. Eli Lilly and Company was involved in the study design, data analysis, and preparation of the manuscript, and provided support for Open Access.
: Jennifer Leohr, Mary Anne Dellva, Kallin Carter, Elizabeth LaBell, and Helle Linnebjerg are employees and shareholders of Eli Lilly and Company.
: All trials were conducted in accordance with the principles of the Declaration of Helsinki (2000), International Council for Harmonisation, and the E6 Guideline for Good Clinical Practice. Institutional review board approval and written informed consent were obtained from all subjects before conducting any evaluations or study procedures.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The datasets during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: The code used and/or analyzed in the current study is available from the corresponding author on reasonable request.
: All authors participated in the interpretation of the study results, and in the drafting, critical revision, and approval of the final version of the manuscript. HL, JL, and MAD were involved in the study design and interpretation of the results. EL was involved in the data extraction. MAD and KC were involved in the statistical analysis. EL and JL conducted the pharmacodynamic and pharmacokinetic analyses.